Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study

被引:0
|
作者
Wu, Yingtong [1 ,2 ]
Che, Yinggang [1 ]
Zhang, Yong [1 ]
Xiong, Yanlu [3 ]
Shu, Chen [3 ]
Jiang, Jun [4 ]
Li, Gaozhi [5 ]
Guo, Lin [6 ]
Qiao, Tianyun [3 ]
Li, Shuwen [2 ]
Li, Ou [2 ]
Chang, Ning [1 ]
Zhang, Xinxin [7 ]
Zhang, Minzhe [1 ]
Qiu, Dan [1 ]
Xi, Hangtian [1 ]
Li, Jinggeng [1 ]
Chen, Xiangxiang [1 ]
Ye, Mingxiang [8 ]
Zhang, Jian [1 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Pulm & Crit Care Med, Xian, Peoples R China
[2] Air Force Healthcare Ctr Special Serv, Sanat 1, Hangzhou, Peoples R China
[3] Air Force Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China
[4] Air Force Med Univ, Dept Hlth Serv, Xian, Peoples R China
[5] Peoples Liberat Army, Unit 94498, Nanyang, Peoples R China
[6] Air Force Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Coll Pulm & Crit Care Med, Med Ctr 8, Beijing, Peoples R China
[8] Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp Med, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
glucosamine; cancer risk; Mendelian randomization; single-nucleotide polymorphisms; causality; PAIN-RELATED DISABILITY; CHONDROITIN SULFATE; CELLS; INHIBITION; EXPRESSION; PROTEIN; AUTOPHAGY; OSTEOARTHRITIS; SUSCEPTIBILITY; HYDROCHLORIDE;
D O I
10.3389/fgene.2024.1293668
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction Observational investigations have examined the impact of glucosamine use on the risk of cancer and non-neoplastic diseases. However, the findings from these studies face limitations arising from confounding variables, reverse causation, and conflicting reports. Consequently, the establishment of a causal relationship between habitual glucosamine consumption and the risk of cancer and non-neoplastic diseases necessitates further investigation.Methods For Mendelian randomization (MR) investigation, we opted to employ single-nucleotide polymorphisms (SNPs) as instruments that exhibit robust associations with habitual glucosamine consumption. We obtained the corresponding effect estimates of these SNPs on the risk of cancer and non-neoplastic diseases by extracting summary data for genetic instruments linked to 49 varied cancer types amounting to 378,284 cases and 533,969 controls, as well as 20 non-neoplastic diseases encompassing 292,270 cases and 842,829 controls. Apart from the primary analysis utilizing inverse-variance weighted MR, we conducted two supplementary approaches to account for potential pleiotropy (MR-Egger and weighted median) and assessed their respective MR estimates. Furthermore, the results of the leave-one-out analysis revealed that there were no outlying instruments.Results Our results suggest divergence from accepted biological understanding, suggesting that genetically predicted glucosamine utilization may be linked to an increased vulnerability to specific illnesses, as evidenced by increased odds ratios and confidence intervals (95% CI) for diseases, such as malignant neoplasm of the eye and adnexa (2.47 [1.34-4.55]), benign neoplasm of the liver/bile ducts (2.12 [1.32-3.43]), benign neoplasm of the larynx (2.01 [1.36-2.96]), melanoma (1.74 [1.17-2.59]), follicular lymphoma (1.50 [1.06-2.11]), autoimmune thyroiditis (2.47 [1.49-4.08]), and autoimmune hyperthyroidism (1.93 [1.17-3.18]). In contrast to prior observational research, our genetic investigations demonstrate a positive correlation between habitual glucosamine consumption and an elevated risk of sigmoid colon cancer, lung adenocarcinoma, and benign neoplasm of the thyroid gland.Conclusion Casting doubt on the purported purely beneficial association between glucosamine ingestion and prevention of neoplastic and non-neoplastic diseases, habitual glucosamine ingestion exhibits dichotomous effects on disease outcomes. Endorsing the habitual consumption of glucosamine as a preventative measure against neoplastic and non-neoplastic diseases cannot be supported.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study
    Harris, Holly R.
    Cushing-Haugen, Kara L.
    Webb, Penelope M.
    Nagle, Christina M.
    Jordan, Susan J.
    Risch, Harvey A.
    Rossing, Mary Anne
    Doherty, Jennifer A.
    Goodman, Marc T.
    Modugno, Francesmary
    Ness, Roberta B.
    Moysich, Kirsten B.
    Kjaer, Susanne K.
    Hogdall, Estrid
    Jensen, Allan
    Schildkraut, Joellen M.
    Berchuck, Andrew
    Cramer, Daniel W.
    Bandera, Elisa V.
    Rodriguez, Lorna
    Wentzensen, Nicolas
    Kotsopoulos, Joanne
    Narod, Steven A.
    McLaughlin, John R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Pearce, Celeste L.
    Wu, Anna H.
    Lindstrom, Sara
    Terry, Kathryn L.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 822 - 830
  • [32] The association between metabolic syndrome and lung cancer risk: a Mendelian randomization study
    Wei, Zhicheng
    Hu, Yunyun
    Zuo, Fang
    Wen, Xiushu
    Wu, Desheng
    Sun, Xiaodong
    Liu, Conghai
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk
    Jung, Su Yon
    Papp, Jeanette C.
    Sobel, Eric M.
    Zhang, Zuo-Feng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Genetically proxied gut microbiota, gut metabolites with risk of epilepsy and the subtypes: A bi-directional Mendelian randomization study
    Ouyang, Yuzhen
    Chen, Yu
    Wang, Ge
    Song, Yanmin
    Zhao, Haiting
    Xiao, Bo
    Yang, Zhuanyi
    Long, Lili
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [35] The causal association between artificial sweeteners and the risk of cancer: a Mendelian randomization study
    Pan, Haotian
    Feng, Chenchen
    Zhou, Ziting
    Huang, Jiamin
    Deng, Jiasi
    Zhou, Yuanyuan
    Wang, Yuxuan
    Mu, Xinru
    Wang, Qian
    Wang, Ke
    Lu, Zhigang
    FOOD & FUNCTION, 2024, 15 (08) : 4527 - 4537
  • [36] Mendelian randomization study: The association between metabolic pathways and colorectal cancer risk
    Jung, Su Yon
    Papp, Jeanette
    Sobel, Eric
    Zhang, Zuo-Feng
    CANCER RESEARCH, 2020, 80 (16)
  • [37] Genetically proxied IL-6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study
    Myserlis, Evangelos Pavlos
    Ray, Anushree
    Anderson, Christopher D.
    Georgakis, Marios K.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (03)
  • [38] Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study
    Huo, Zhenyu
    Ge, Fan
    Li, Caichen
    Cheng, Heting
    Lu, Yi
    Wang, Runchen
    Wen, Yaokai
    Yue, Keqi
    Pan, Zixuan
    Peng, Haoxin
    Wu, Xiangrong
    Liang, Hengrui
    He, Jianxing
    Liang, Wenhua
    SLEEP MEDICINE, 2021, 87 : 183 - 190
  • [39] Associations Between Genetically Predicted Iron Status and Cardiovascular Disease Risk: A Mendelian Randomization Study
    Barad, Alexa
    Clark, Andrew G.
    Pressman, Eva K.
    O'Brien, Kimberly O.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (11):
  • [40] Association between diverticular disease and colorectal cancer: a bidirectional mendelian randomization study
    Zhang, Yanxi
    Zhang, Han
    Zhu, Jinghan
    He, Yazhou
    Wang, Peng
    Li, Doudou
    Liu, Xiaozhuan
    Jin, Wen
    Zhang, Junxi
    Xu, Chuan
    Yu, Zengli
    Zhao, Xin
    Cui, Lingling
    BMC CANCER, 2023, 23 (01)